BPN-14770 Uses, Dosage, Side Effects and more
BPN-14770 is under investigation in clinical trial NCT02840279 (A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female Subjects).
| Trade Name | BPN-14770 |
| Generic | BPN-14770 |
| Type | |
| Formula | C19H14ClF3N4O |
| Weight | Average: 406.79 Monoisotopic: 406.0808233 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
